Cargando…

ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?

Detalles Bibliográficos
Autores principales:	Pagliaro, Pasquale, Penna, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314898/ https://www.ncbi.nlm.nih.gov/pubmed/32626721 http://dx.doi.org/10.3389/fmed.2020.00335

Ejemplares similares

Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management
por: Liu, Mengyuan, et al.
Publicado: (2020)

Comment on “Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management”
por: Sahin, Mustafa, et al.
Publicado: (2020)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020)

ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis
por: Verma, Saguna, et al.
Publicado: (2020)

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
por: Akbari, Mohammadarian, et al.
Publicado: (2022)

Pathophysiology of COVID-19: Everywhere You Look You Will See ACE(2)!
por: Cousin, Vladimir L., et al.
Publicado: (2021)

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
por: Sabater Molina, Maria, et al.
Publicado: (2022)

ACE and ACE2: insights from Drosophila and implications for COVID-19
por: Herrera, Paul, et al.
Publicado: (2021)

The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences
por: Barash, Ayelet, et al.
Publicado: (2020)

Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis
por: Song, Jukun, et al.
Publicado: (2020)

Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
por: Bourgonje, Arno R, et al.
Publicado: (2020)

ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease
por: Skarstein Kolberg, Espen
Publicado: (2020)

Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease
por: Najafi, Mojtaba, et al.
Publicado: (2022)

ACE2 pathway regulates thermogenesis and energy metabolism
por: Cao, Xi, et al.
Publicado: (2022)

ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions
por: Hsieh, Wen-Yeh, et al.
Publicado: (2012)

Genetic Landscape of the ACE2 Coronavirus Receptor
por: Yang, Zhijian, et al.
Publicado: (2022)

COVID-19 and the Heart: ACE2 Level and the Company it Keeps Hold the Key
por: Lin, Han-Bin, et al.
Publicado: (2020)

ACE2, Metformin, and COVID-19
por: Malhotra, Atul, et al.
Publicado: (2020)

Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19
por: Galán, María, et al.
Publicado: (2020)

ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients
por: Fan, Caibin, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
por: Zemlin, Annalise E, et al.
Publicado: (2020)

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
por: Gómez, Juan, et al.
Publicado: (2020)

ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men
por: Martínez-Gómez, Laura E., et al.
Publicado: (2022)

Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
por: Faustine, Ingrid, et al.
Publicado: (2023)

Correction: ACE2 pathway regulates thermogenesis and energy metabolism
por: Cao, Xi, et al.
Publicado: (2022)

Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
por: Rubattu, Speranza, et al.
Publicado: (2020)

Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007)

A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019
por: Wang, Weiqi, et al.
Publicado: (2020)

COVID-19: Acing the Treatment
por: Hunter, Jez, et al.
Publicado: (2022)

Sex difference in circulating soluble form of ACE2 protein in moderate and severe COVID-19 and healthy controls
por: Robertson, Josefina, et al.
Publicado: (2022)

COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease
por: Gan, Rosemary, et al.
Publicado: (2020)

Scientific Hypothesis for Treatment of COVID‐19′s Lung Lesions by Adjusting ACE/ACE2 Imbalance
por: Ferrara, F., et al.
Publicado: (2021)

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
por: Jevnikar, Kristina, et al.
Publicado: (2022)

Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients
por: Mahmood, Zainab S., et al.
Publicado: (2022)

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
por: Bosso, Mira, et al.
Publicado: (2020)

Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020)

Genetic variations affecting ACE2 protein stability in minority populations
por: Mahase, Vidhyanand, et al.
Publicado: (2022)

Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19
por: Li, Xiao-Zhi, et al.
Publicado: (2021)

The effect of omega-3 supplements on the serum levels of ACE/ACE2 ratio as a potential key in cardiovascular disease: A randomized clinical trial in participants with vitamin D deficiency
por: Daboul, Sara M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3f144cdj1m4cu5a761dfulu3aq